INS and type 2 diabetes mellitus: With a worldwide prevalence projected to reach over 700 million patients by 2045 [1], type 2 diabetes (T2D) is a chronic metabolic disease marked by hyperglycemia and linked with insulin resistance and/or insufficient production of pancreatic insulin.